Search Images Maps Play Gmail Drive Calendar Translate More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberWO2003080818 A1
Publication typeApplication
Application numberPCT/JP2003/003868
Publication date2 Oct 2003
Filing date27 Mar 2003
Priority date27 Mar 2002
Also published asEP1489163A1, EP1489163A4, US20050226852
Publication numberPCT/2003/3868, PCT/JP/2003/003868, PCT/JP/2003/03868, PCT/JP/3/003868, PCT/JP/3/03868, PCT/JP2003/003868, PCT/JP2003/03868, PCT/JP2003003868, PCT/JP200303868, PCT/JP3/003868, PCT/JP3/03868, PCT/JP3003868, PCT/JP303868, WO 03080818 A1, WO 03080818A1, WO 2003/080818 A1, WO 2003080818 A1, WO 2003080818A1, WO-A1-03080818, WO-A1-2003080818, WO03080818 A1, WO03080818A1, WO2003/080818A1, WO2003080818 A1, WO2003080818A1
InventorsMasahiro Toda, Hideyuki Okano, Yutaka Kawakami, Yoshiaki Toyama, Yuji Mikami, Masanori Sakaguchi
ApplicantInstitute Of Gene And Brain Science
Export CitationBiBTeX, EndNote, RefMan
External Links: Patentscope, Espacenet
Methode permettant d'induire la croissance des cellules souches nerveuses
WO 2003080818 A1
Non-Patent Citations
Reference
1 *ARSENIJEVIC Y. ET AL.: "Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2", J. NEUROSCI., vol. 21, no. 18, 2001, pages 7194 - 7202, XP002220612
2 *See also references of EP1489163A4
3 *TROPEPE V. ET AL.: "Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon", DEV. BIOL., vol. 208, no. 1, 1999, pages 166 - 188, XP001033948
4 *WANG Q. ET AL.: "Dendritic cells support hematopoiesis of bone marrow cells", TRANSPLANTATION, vol. 72, no. 5, 2001, pages 891 - 899, XP002970269
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
WO2006008582A1 *29 Dec 200426 Jan 2006Sygnis Bioscience Gmbh / Co. KgTreatment of neurological disorders with hematopoeitic growth factors
WO2006085587A1 *9 Feb 200617 Aug 2006Keio Universityニューロスフェア形成剤
Classifications
International ClassificationA61P25/00, C12N5/02, C12N5/0797
Cooperative ClassificationC12N5/0623, C12N2501/22, C12N2501/11, C12N2506/11, C12N2501/115
European ClassificationC12N5/06B8P
Legal Events
DateCodeEventDescription
2 Oct 2003ALDesignated countries for regional patents
Kind code of ref document: A1
Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
2 Oct 2003AKDesignated states
Kind code of ref document: A1
Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW
3 Dec 2003121Ep: the epo has been informed by wipo that ep was designated in this application
22 Sep 2004WWEWipo information: entry into national phase
Ref document number: 2003578547
Country of ref document: JP
6 Oct 2004WWEWipo information: entry into national phase
Ref document number: 2003715540
Country of ref document: EP
22 Dec 2004WWPWipo information: published in national office
Ref document number: 2003715540
Country of ref document: EP
14 Jun 2005WWEWipo information: entry into national phase
Ref document number: 10509529
Country of ref document: US